| 2021 | | Cholecystectomy, porta hepatis stripping, and omental bursectomy | 손주혁, 장석준 |
| 2024 | | Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines | 손주혁, 장석준 |
| 2019 | | Comparison of posterior rectal dissection techniques during rectosigmoid colon resection as part of cytoreductive surgery in patients with epithelial ovarian cancer: Close rectal dissection versus total mesorectal excision | 공태욱, 백지흠, 손주혁, 유희석, 장석준 |
| 2024 | | Effect of high-dose polymeric nanoparticle micellar paclitaxel on improved progression-free survival in patients with optimally resected stage III or IV high-grade carcinoma of the ovary: a prospective cohort study with historical controls | 공태욱, 손주혁, 장석준 |
| 2021 | | Extrapelvic bowel resection and anastomosis in cytoreductive surgery for ovarian cancer | 손주혁, 장석준 |
| 2023 | | Fertility-sparing hormonal treatment in patients with stage I endometrial cancer of grade 2 without myometrial invasion and grade 1–2 with superficial myometrial invasion: Gynecologic Oncology Research Investigators coLLaborAtion study (GORILLA-2001) | 공태욱, 김지연, 손주혁, 장석준 |
| 2022 | | Gastrointestinal/genitourinary perforation and fistula formation with or without bevacizumab in patients with previously irradiated recurrent cervical cancer: a Korean multicenter retrospective study of the Gynecologic Oncology Research Investigators Collaboration (GORILLA) group (GORILLA-1001) | 공태욱, 손주혁, 장석준 |
| 2022 | | Gynecologic cancer clinical practice guidelines in Korea and current issues | 공태욱, 김지연, 손주혁, 장석준 |
| 2023 | | Impact of PARP inhibitor maintenance therapy in newly diagnosed advanced epithelial ovarian cancer: A meta-analysis | 손주혁, 장석준 |
| 2023 | | Is minimally invasive radical surgery safe for patients with cervical cancer ≤2 cm in size? (MISAFE): Gynecologic Oncology Research Investigators coLLborAtion study (GORILLA-1003) | 공태욱, 김지연, 손주혁, 장석준 |
| 2024 | | Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancer | 공태욱, 손주혁 |
| 2023 | | Optimum selection criteria for secondary cytoreductive surgery in patients with recurrent epithelial ovarian cancer: A multicenter study from the Gynecologic Oncology Research Investigators coLLaborAtion group (GORILLA-3001) | 공태욱, 손주혁, 장석준 |
| 2020 | | Prognostic analysis of splenic parenchymal metastasis in advanced ovarian cancer: Does parenchymal metastasis matter? | 공태욱, 백지흠, 손주혁, 장석준 |
| 2020 | | Prognostic factors influencing pelvic, extra-pelvic, and intraperitoneal recurrences in lymph node-negative early-stage cervical cancer patients following radical hysterectomy | 공태욱, 백지흠, 손주혁, 장석준 |
| 2023 | | Risk factors for the failure of first-line PARP inhibitor maintenance therapy in patients with advanced ovarian cancer: Gynecologic Oncology Research Investigators Collaboration Study (GORILLA-3004) | 공태욱, 김지연, 손주혁, 장석준 |
| 2020 | | Selection criteria and colpotomic approach for safe minimally invasive radical hysterectomy in early-stage cervical cancer | 공태욱, 백지흠, 손주혁, 유희석, 장석준 |
| 2023 | | Significance of cholecystectomy in cytoreductive surgery for advanced ovarian cancer | 공태욱, 김지연, 손주혁, 장석준 |
| 2022 | | Simplified Selection Criteria for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer | 공태욱, 김지연, 손주혁, 장석준 |
| 2020 | | Spillage and displacement of ICG-stained tissue from the uterine cervix to the pelvic peritoneum: A proof of concept study for colpotomic approach in minimally invasive surgery | 공태욱, 백지흠, 손주혁, 장석준 |
| 2020 | | Survival outcomes of FIGO stage IIIC and IVB endometrial cancer patients presenting primarily as nodal spreads without peritoneal carcinomatosis | 공태욱, 백지흠, 손주혁, 장석준 |
| 2021 | | Treatment outcomes and complications in FIGO stage IIIC and IVB endometrioid endometrial cancer patients presenting as nodal spreads following systematic lymphadenectomy and adjuvant therapy | 공태욱, 백지흠, 손주혁, 장석준 |
